FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      ·

      abbvbmydva

      ·

      US Considers 100% Tariffs on Branded and Patented Drugs, Stocks Decline

      Several stocks experienced significant declines during the afternoon trading session as news emerged regarding potential tariffs on imported branded and patented drugs. The proposed tariffs could reach as high as 100%, raising concerns among investors about the implications for pharmaceutical companies.

      Companies such as AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie saw their shares plummet in response to the tariff discussions. The market reaction reflects apprehension over how these tariffs might affect pricing and availability of medications in the United States.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud